Novo Nordisk and Eli Lilly are currently a duopoly in the obesity market, which reached a value of $24 billion last year ...

Wegovy, a semaglutide injection, aids in weight loss by suppressing appetite and boosting metabolism, now available in South ...

Merck (NYSE: MRK) is hungrily looking to take a bite out of the weight-loss drugs market. Merck on Dec. 16 said it had just ...

Lilly investors got the jitters, saw better opportunities elsewhere, or decided to hold onto their chips. In the third ...

Starting January 1, the cost of the popular weight loss medication Wegovy will drop significantly in Israel—but only for its ...

The term “holiday blues” is described as temporary feelings of anxiety, depression, and sadness during the holiday season.

"We spend more on administrative costs than we do on caring for heart disease and caring for cancer," said Harvard University economist David Cutler. And medical bills accounted for more than half of ...

The main opposition Democratic Party (DP) on Sunday urged acting President Han Duck-soo to quickly promulgate special counsel bills against President Yoon Suk Yeol and first lady K... South Korea and ...